Tag: disease surveillance

  • Scientists at U.S. Government Lab Charged With Smuggling Deactivated Mpox Virus Into America

    Scientists at U.S. Government Lab Charged With Smuggling Deactivated Mpox Virus Into America

    Two scientists employed at a U.S. government research laboratory have been charged with smuggling deactivated mpox virus samples into the United States from Africa and allegedly making false statements to federal authorities during an airport inspection.

    Federal prosecutors unsealed a criminal complaint Tuesday against Vincent Munster, chief of the Virus Ecology Section at Rocky Mountain Laboratories in Hamilton, Montana, and his colleague Claude Kwe.

    Authorities allege the two researchers attempted to bring vials containing deactivated mpox virus into the United States without declaring them or obtaining the required authorization.

    Airport Inspection Leads to Investigation

    According to court documents, Munster and Kwe were stopped by customs officials at Detroit Metropolitan Airport in January after returning from a nine-day trip to the Republic of the Congo via Paris.

    Investigators said Munster denied carrying biological materials or scientific samples into the country. However, subsequent testing allegedly revealed that the scientists possessed vials containing inactivated mpox virus.

    The FBI claims the samples were not declared to customs officials and that the researchers lacked the necessary permits required for transporting biological materials across international borders.

    Authorities further allege that Munster falsely assured investigators that any required documentation was stored on his laptop, reportedly telling officers, “I do this all the time.”

    Federal investigators contend those statements were materially false.

    Public Health and Security Concerns

    The case has attracted significant attention because it involves researchers working within the U.S. government’s public health system.

    Marcus Sykes of the Department of Health and Human Services Office of Inspector General said that deliberately concealing biological materials from customs authorities represents a serious breach of public trust and could potentially create public health risks.

    Officials have emphasized that the charges relate to alleged violations of importation and reporting requirements rather than accusations that the virus itself was active or capable of causing infection.

    The samples involved were reportedly deactivated, meaning the virus had been rendered noninfectious.

    Researchers With Extensive Mpox Experience

    Court filings indicate both scientists have extensive backgrounds studying mpox and other emerging infectious diseases.

    Authorities did not specify why the researchers allegedly attempted to transport the samples without authorization, nor did court documents explain what research purpose the materials may have served.

    Munster and Kwe are scheduled to appear in federal court in Missoula, Montana.

    Understanding Mpox

    Mpox, formerly known as monkeypox, is a viral disease caused by the mpox virus. Common symptoms include fever, swollen lymph nodes, fatigue, and a distinctive rash. While most patients recover fully, severe illness can occur in some cases.

    The virus was first identified in 1958 during outbreaks among research monkeys, though it primarily circulates among animals and humans in parts of Central and West Africa.

    Global awareness of mpox increased dramatically in 2022 when outbreaks spread across more than 70 countries. Researchers confirmed that person-to-person transmission could occur through close physical contact, including sexual contact.

    The recent outbreak in the Democratic Republic of the Congo led to thousands of deaths before health authorities declared the two-year outbreak over in April 2026.

  • Brazil Monitoring Two Suspected Ebola Cases as Health Authorities Activate Emergency Protocols

    Brazil Monitoring Two Suspected Ebola Cases as Health Authorities Activate Emergency Protocols

    Health authorities in Brazil are monitoring two patients for possible Ebola infections in the country’s largest cities, São Paulo and Rio de Janeiro, amid concerns over a growing outbreak in Africa.

    Officials in São Paulo reported that a 37-year-old man from Democratic Republic of the Congo developed symptoms including fever and is undergoing testing for the virus. Meanwhile, health authorities in Rio de Janeiro activated emergency safety protocols after a Belgian traveler who recently arrived from Uganda displayed symptoms such as cough, chills, and diarrhea.

    Laboratory results for both patients are expected next week.

    If either case is confirmed, it would mark the first Ebola infection detected outside Africa since the current outbreak began in the Democratic Republic of the Congo.

    The outbreak has already resulted in more than 1,000 suspected cases in DR Congo and at least 246 deaths. Uganda has also reported nine confirmed infections and one fatality linked to the disease.

    Health officials note that both patients in Brazil have already received separate diagnoses. The patient in São Paulo tested positive for meningitis and remains in serious condition, while the traveler in Rio de Janeiro was diagnosed with malaria. However, authorities stress that these findings do not eliminate the possibility of a simultaneous Ebola infection.

    The current outbreak is being driven by the rare Bundibugyo strain of the Ebola virus, a variant for which there is currently no proven vaccine. Historically, the strain has carried a fatality rate of roughly one-third of infected patients.

    Ebola is a viral disease that is believed to originate in animals, particularly fruit bats, before spreading to humans through contact with infected animals or their bodily fluids. Human-to-human transmission occurs through direct contact with bodily fluids such as blood, saliva, sweat, urine, vomit, semen, or feces from an infected individual.

    Over the weekend, Médecins Sans Frontières (MSF) warned that the outbreak has reached an “alarming” stage, citing the unusually rapid rise in cases during the early phase of the epidemic.

    At the same time, Tedros Adhanom Ghebreyesus is visiting the heavily affected Ituri province in DR Congo to oversee containment and response efforts.

    Despite the suspected cases in Brazil, the World Health Organization has repeatedly emphasized that the risk of widespread global transmission remains low and that international spread of the outbreak is considered highly unlikely.

    Health officials in Brazil continue to monitor both patients closely while awaiting definitive test results that will determine whether the country is facing its first Ebola cases linked to the ongoing African outbreak.